-
1
-
-
0033870207
-
Unravelling the heterogeneity of non insulin dependent diabetes
-
Pearson E.R., and Hattersley A.T. Unravelling the heterogeneity of non insulin dependent diabetes. J. R. Coll. Physicians Lond. 34 (2000) 332-335
-
(2000)
J. R. Coll. Physicians Lond.
, vol.34
, pp. 332-335
-
-
Pearson, E.R.1
Hattersley, A.T.2
-
2
-
-
27144453762
-
Molecular genetics goes to the diabetes clinic
-
Hattersley A.T. Molecular genetics goes to the diabetes clinic. Clin. Med. 5 (2005) 476-481
-
(2005)
Clin. Med.
, vol.5
, pp. 476-481
-
-
Hattersley, A.T.1
-
3
-
-
0035557623
-
Molecular diagnostics in monogenic and multifactorial forms of type 2 diabetes
-
McCarthy M.I., and Hattersley A.T. Molecular diagnostics in monogenic and multifactorial forms of type 2 diabetes. Expert Rev. Mol. Diagn. 1 (2001) 403-412
-
(2001)
Expert Rev. Mol. Diagn.
, vol.1
, pp. 403-412
-
-
McCarthy, M.I.1
Hattersley, A.T.2
-
4
-
-
0031914679
-
Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity
-
Hattersley A.T. Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity. Diabet. Med. 15 (1998) 15-24
-
(1998)
Diabet. Med.
, vol.15
, pp. 15-24
-
-
Hattersley, A.T.1
-
5
-
-
0016244025
-
Mild familial diabetes with dominant inheritance
-
Tattersall R.B. Mild familial diabetes with dominant inheritance. Q. J. Med. 43 (1974) 339-357
-
(1974)
Q. J. Med.
, vol.43
, pp. 339-357
-
-
Tattersall, R.B.1
-
6
-
-
0031892442
-
Maturity-onset diabetes of the young: a clinical history
-
Tattersall R.B. Maturity-onset diabetes of the young: a clinical history. Diabet. Med. 15 (1998) 11-14
-
(1998)
Diabet. Med.
, vol.15
, pp. 11-14
-
-
Tattersall, R.B.1
-
7
-
-
0035960122
-
Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
-
Fajans S.S., Bell G.I., and Polonsky K.S. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N. Engl. J. Med. 345 (2001) 971-980
-
(2001)
N. Engl. J. Med.
, vol.345
, pp. 971-980
-
-
Fajans, S.S.1
Bell, G.I.2
Polonsky, K.S.3
-
8
-
-
0028087153
-
Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree
-
Herman W.H., Fajans S.S., Ortiz F.J., Smith M.J., Sturis J., Bell G.I., et al. Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree. Diabetes 43 (1994) 40-46
-
(1994)
Diabetes
, vol.43
, pp. 40-46
-
-
Herman, W.H.1
Fajans, S.S.2
Ortiz, F.J.3
Smith, M.J.4
Sturis, J.5
Bell, G.I.6
-
9
-
-
0025854216
-
Maturity onset-type diabetes of the young (MODY): one condition or many?
-
Tattersall R.B., and Mansell P.I. Maturity onset-type diabetes of the young (MODY): one condition or many?. Diabet. Med. 8 (1991) 402-410
-
(1991)
Diabet. Med.
, vol.8
, pp. 402-410
-
-
Tattersall, R.B.1
Mansell, P.I.2
-
10
-
-
0026562918
-
Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus
-
Vionnet N., Stoffel M., Takeda J., Yasuda K., Bell G.I., Zouali H., et al. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature 356 (1992) 721-722
-
(1992)
Nature
, vol.356
, pp. 721-722
-
-
Vionnet, N.1
Stoffel, M.2
Takeda, J.3
Yasuda, K.4
Bell, G.I.5
Zouali, H.6
-
11
-
-
10544236911
-
Mutations in the hepatocyte nuclear factor-4α gene in the maturity-onset diabetes of the young (MODY1)
-
Yamagata K., Furuta H., Oda N., Kaisaki P.J., Menzel S., Cox N.J., et al. Mutations in the hepatocyte nuclear factor-4α gene in the maturity-onset diabetes of the young (MODY1). Nature 384 (1996) 458-460
-
(1996)
Nature
, vol.384
, pp. 458-460
-
-
Yamagata, K.1
Furuta, H.2
Oda, N.3
Kaisaki, P.J.4
Menzel, S.5
Cox, N.J.6
-
12
-
-
10544249874
-
Mutations in the hepatocyte nuclear factor-1a gene in maturity-onset diabetes of the young (MODY3)
-
Yamagata K., Oda N., Kaisaki P.J., Menzel S., Furuta H., Vaxillaire M., et al. Mutations in the hepatocyte nuclear factor-1a gene in maturity-onset diabetes of the young (MODY3). Nature 384 (1996) 455-458
-
(1996)
Nature
, vol.384
, pp. 455-458
-
-
Yamagata, K.1
Oda, N.2
Kaisaki, P.J.3
Menzel, S.4
Furuta, H.5
Vaxillaire, M.6
-
14
-
-
0031453186
-
Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY
-
Horikawa Y., Iwasaki N., Hara M., Furuta H., Hinokio Y., Cockburn B.N., et al. Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat. Genet. 17 (1997) 384-385
-
(1997)
Nat. Genet.
, vol.17
, pp. 384-385
-
-
Horikawa, Y.1
Iwasaki, N.2
Hara, M.3
Furuta, H.4
Hinokio, Y.5
Cockburn, B.N.6
-
15
-
-
0032700272
-
Mutations in the NEUROD1 gene are associated with the development of type 2 diabetes mellitus
-
Malecki M.T., Jhala U.S., Antonellis A., Fields L., Doria A., Orban T., et al. Mutations in the NEUROD1 gene are associated with the development of type 2 diabetes mellitus. Nat. Genet. 23 (1999) 323-328
-
(1999)
Nat. Genet.
, vol.23
, pp. 323-328
-
-
Malecki, M.T.1
Jhala, U.S.2
Antonellis, A.3
Fields, L.4
Doria, A.5
Orban, T.6
-
16
-
-
0022538272
-
Tissue-specific expression of glucokinase: identification of the gene product in liver and pancreatic islets
-
Iynedjian P.B., Mobius G., Seitz H.J., Wollheim C.B., and Renold A.E. Tissue-specific expression of glucokinase: identification of the gene product in liver and pancreatic islets. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 1998-2001
-
(1986)
Proc. Natl. Acad. Sci. U.S.A.
, vol.83
, pp. 1998-2001
-
-
Iynedjian, P.B.1
Mobius, G.2
Seitz, H.J.3
Wollheim, C.B.4
Renold, A.E.5
-
17
-
-
29444440400
-
Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction
-
Raeder H., Johansson S., Holm P.I., Haldorsen I.S., Mas E., Sbarra V., et al. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat. Genet. 38 (2006) 54-62
-
(2006)
Nat. Genet.
, vol.38
, pp. 54-62
-
-
Raeder, H.1
Johansson, S.2
Holm, P.I.3
Haldorsen, I.S.4
Mas, E.5
Sbarra, V.6
-
18
-
-
41149139275
-
Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young
-
European Molecular Genetics Quality Network (EMQN) MODY group
-
Ellard S., Bellanné-Chantelot C., Hattersley A.T., and European Molecular Genetics Quality Network (EMQN) MODY group. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 51 (2008) 546-553
-
(2008)
Diabetologia
, vol.51
, pp. 546-553
-
-
Ellard, S.1
Bellanné-Chantelot, C.2
Hattersley, A.T.3
-
19
-
-
0029986387
-
Glucokinase mutations, insulin secretion, and diabetes mellitus
-
Bell G.I., Pilkis S.J., Weber I.T., and Polonsky K.S. Glucokinase mutations, insulin secretion, and diabetes mellitus. Annu. Rev. Physiol. 58 (1996) 171-186
-
(1996)
Annu. Rev. Physiol.
, vol.58
, pp. 171-186
-
-
Bell, G.I.1
Pilkis, S.J.2
Weber, I.T.3
Polonsky, K.S.4
-
20
-
-
0027472126
-
Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus
-
Froguel P., Zouali H., Vionnet N., Velho G., Vaxillaire M., Sun F., et al. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N. Engl. J. Med. 328 (1993) 697-702
-
(1993)
N. Engl. J. Med.
, vol.328
, pp. 697-702
-
-
Froguel, P.1
Zouali, H.2
Vionnet, N.3
Velho, G.4
Vaxillaire, M.5
Sun, F.6
-
21
-
-
0035122350
-
Beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations
-
Pearson E.R., Velho G., Clark P., Stride A., Shepherd M., Frayling T.M., et al. Beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations. Diabetes 50 Suppl. 1 (2001) S101-S107
-
(2001)
Diabetes
, vol.50
, Issue.SUPPL. 1
-
-
Pearson, E.R.1
Velho, G.2
Clark, P.3
Stride, A.4
Shepherd, M.5
Frayling, T.M.6
-
22
-
-
0034000635
-
A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria
-
Ellard S., Beards F., Allen L.I., Shepherd M., Ballantyne E., Harvey R., et al. A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria. Diabetologia 43 (2000) 250-253
-
(2000)
Diabetologia
, vol.43
, pp. 250-253
-
-
Ellard, S.1
Beards, F.2
Allen, L.I.3
Shepherd, M.4
Ballantyne, E.5
Harvey, R.6
-
23
-
-
33646778478
-
Minireview: pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology, and genetics in diabetes
-
Hattersley A.T., and Pearson E.R. Minireview: pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology, and genetics in diabetes. Endocrinology 147 (2006) 2657-2663
-
(2006)
Endocrinology
, vol.147
, pp. 2657-2663
-
-
Hattersley, A.T.1
Pearson, E.R.2
-
24
-
-
41149174380
-
Finding a glucokinase mutation alters patient treatment
-
Gill-Carey O., Shields B., Colclough K., Ellard S., Hattersley A.T., et al. Finding a glucokinase mutation alters patient treatment. Diabet. Med. 24 Suppl. 1 (2007) S6-S7
-
(2007)
Diabet. Med.
, vol.24
, Issue.SUPPL. 1
-
-
Gill-Carey, O.1
Shields, B.2
Colclough, K.3
Ellard, S.4
Hattersley, A.T.5
-
25
-
-
33646790589
-
Fetal growth is altered by fetal genotype and not insulin treatment of maternal hyperglycaemia in gestational diabetes due to mutations in the glucokinase gene
-
Spyer G., Ballantyne E., Shepherd M., Allen L., Macleod K., Ellard S., et al. Fetal growth is altered by fetal genotype and not insulin treatment of maternal hyperglycaemia in gestational diabetes due to mutations in the glucokinase gene. Diabet. Med. 17 Suppl. A (2000) 40
-
(2000)
Diabet. Med.
, vol.17
, Issue.SUPPL. A
, pp. 40
-
-
Spyer, G.1
Ballantyne, E.2
Shepherd, M.3
Allen, L.4
Macleod, K.5
Ellard, S.6
-
26
-
-
0034914347
-
Influence of maternal and fetal glucokinase mutations in gestational diabetes
-
Spyer G., Hattersley A.T., Sykes J.E., Sturley R.H., and MacLeod K.M. Influence of maternal and fetal glucokinase mutations in gestational diabetes. Am. J. Obstet. Gynecol. 185 (2001) 240-241
-
(2001)
Am. J. Obstet. Gynecol.
, vol.185
, pp. 240-241
-
-
Spyer, G.1
Hattersley, A.T.2
Sykes, J.E.3
Sturley, R.H.4
MacLeod, K.M.5
-
27
-
-
0036200587
-
Liver-enriched transcription factors in liver function and development. Part I. The hepatocyte nuclear factor network and liver-specific gene expression
-
Schrem H., Klempnauer J., and Borlak J. Liver-enriched transcription factors in liver function and development. Part I. The hepatocyte nuclear factor network and liver-specific gene expression. Pharmacol. Rev. 54 (2002) 129-158
-
(2002)
Pharmacol. Rev.
, vol.54
, pp. 129-158
-
-
Schrem, H.1
Klempnauer, J.2
Borlak, J.3
-
28
-
-
0035512077
-
Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism
-
Shih D.Q., Screenan S., Munoz K.N., Philipson L., Pontoglio M., Yaniv M., et al. Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes 50 (2001) 2472-2480
-
(2001)
Diabetes
, vol.50
, pp. 2472-2480
-
-
Shih, D.Q.1
Screenan, S.2
Munoz, K.N.3
Philipson, L.4
Pontoglio, M.5
Yaniv, M.6
-
29
-
-
0031985396
-
A newly discovered role of transcription factors involved in pancreas development and the pathogenesis of diabetes mellitus
-
Habener J.F., and Stoffers D.A. A newly discovered role of transcription factors involved in pancreas development and the pathogenesis of diabetes mellitus. Proc. Assoc. Am. Physicians 110 (1998) 12-21
-
(1998)
Proc. Assoc. Am. Physicians
, vol.110
, pp. 12-21
-
-
Habener, J.F.1
Stoffers, D.A.2
-
30
-
-
0030886674
-
Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice
-
Naya F.J., Huang H.P., Qiu Y., Mutoh H., DeMayo F.J., Leiter A.B., et al. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes Dev. 11 (1997) 2323-2334
-
(1997)
Genes Dev.
, vol.11
, pp. 2323-2334
-
-
Naya, F.J.1
Huang, H.P.2
Qiu, Y.3
Mutoh, H.4
DeMayo, F.J.5
Leiter, A.B.6
-
31
-
-
0035122282
-
Beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors
-
Frayling T.M., Evans J.C., Bulman M.P., Pearson E., Allen L., Owen K., et al. Beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes 50 Suppl. 1 (2001) S94-S100
-
(2001)
Diabetes
, vol.50
, Issue.SUPPL. 1
-
-
Frayling, T.M.1
Evans, J.C.2
Bulman, M.P.3
Pearson, E.4
Allen, L.5
Owen, K.6
-
32
-
-
0031894649
-
Chronic diabetic complications in patients with MODY3 diabetes
-
Isomaa B., Henricsson M., Lehto M., Forsblom C., Karanko S., Sarelin L., et al. Chronic diabetic complications in patients with MODY3 diabetes. Diabetologia 41 (1998) 467-473
-
(1998)
Diabetologia
, vol.41
, pp. 467-473
-
-
Isomaa, B.1
Henricsson, M.2
Lehto, M.3
Forsblom, C.4
Karanko, S.5
Sarelin, L.6
-
33
-
-
55949131121
-
Molecular background and clinical characteristics of HNF1A MODY in a Polish population
-
Skupien J., Gorczynska-Kosiorz S., Klupa T., Cyganek K., Wanic K., Borowiec M., et al. Molecular background and clinical characteristics of HNF1A MODY in a Polish population. Diabetes Metab. 34 (2008) 524-528
-
(2008)
Diabetes Metab.
, vol.34
, pp. 524-528
-
-
Skupien, J.1
Gorczynska-Kosiorz, S.2
Klupa, T.3
Cyganek, K.4
Wanic, K.5
Borowiec, M.6
-
34
-
-
0033847575
-
Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes
-
Pearson E.R., Liddell W.G., Shepherd M., Corrall R.J., and Hattersley A.T. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes. Diabet. Med. 17 (2000) 543-545
-
(2000)
Diabet. Med.
, vol.17
, pp. 543-545
-
-
Pearson, E.R.1
Liddell, W.G.2
Shepherd, M.3
Corrall, R.J.4
Hattersley, A.T.5
-
35
-
-
0142186278
-
Genetic cause of hyperglycaemia and response to treatment in diabetes
-
Pearson E.R., Starkey B.J., Powell R.J., Gribble F.M., Clark P.M., and Hattersley A.T. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 362 (2003) 1275-1281
-
(2003)
Lancet
, vol.362
, pp. 1275-1281
-
-
Pearson, E.R.1
Starkey, B.J.2
Powell, R.J.3
Gribble, F.M.4
Clark, P.M.5
Hattersley, A.T.6
-
36
-
-
0042071600
-
Sulphonylurea action revisited: the post-cloning era
-
Gribble F.M., and Reimann F. Sulphonylurea action revisited: the post-cloning era. Diabetologia 46 (2003) 875-891
-
(2003)
Diabetologia
, vol.46
, pp. 875-891
-
-
Gribble, F.M.1
Reimann, F.2
-
37
-
-
0031684710
-
A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene
-
Menzel R., Kaisaki P.J., Rjasanowski I., Heinke P., Kerner W., and Menzel S. A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene. Diabet. Med. 15 (1998) 816-820
-
(1998)
Diabet. Med.
, vol.15
, pp. 816-820
-
-
Menzel, R.1
Kaisaki, P.J.2
Rjasanowski, I.3
Heinke, P.4
Kerner, W.5
Menzel, S.6
-
38
-
-
0034304925
-
HNF1alpha controls renal glucose reabsorption in mouse and man
-
Pontoglio M., Prie D., Cheret C., Doyen A., Leroy C., Froguel P., et al. HNF1alpha controls renal glucose reabsorption in mouse and man. EMBO Rep. 1 (2000) 359-365
-
(2000)
EMBO Rep.
, vol.1
, pp. 359-365
-
-
Pontoglio, M.1
Prie, D.2
Cheret, C.3
Doyen, A.4
Leroy, C.5
Froguel, P.6
-
39
-
-
21544451980
-
Beta-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1alpha mutation carriers
-
Stride A., Ellard S., Clark P., Shakespeare L., Salzmann M., Shepherd M., et al. Beta-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1alpha mutation carriers. Diabetes Care 28 (2005) 1751-1756
-
(2005)
Diabetes Care
, vol.28
, pp. 1751-1756
-
-
Stride, A.1
Ellard, S.2
Clark, P.3
Shakespeare, L.4
Salzmann, M.5
Shepherd, M.6
-
40
-
-
49649099316
-
Clinical application of 1,5-anhydroglucitol measurements in patients with hepatocyte nuclear factor-1alpha maturity-onset diabetes of the young
-
Skupien J., Gorczynska-Kosiorz S., Klupa T., Wanic K., Button E.A., Sieradzki J., et al. Clinical application of 1,5-anhydroglucitol measurements in patients with hepatocyte nuclear factor-1alpha maturity-onset diabetes of the young. Diabetes Care 31 (2008) 1496-1501
-
(2008)
Diabetes Care
, vol.31
, pp. 1496-1501
-
-
Skupien, J.1
Gorczynska-Kosiorz, S.2
Klupa, T.3
Wanic, K.4
Button, E.A.5
Sieradzki, J.6
-
41
-
-
33644813829
-
Renal malformations may be linked to mutations in the hepatocyte nuclear factor-1alpha (MODY3) gene
-
Malecki M.T., Skupien J., Gorczynska-Kosiorz S., Klupa T., Nazim J., Moczulski D.K., et al. Renal malformations may be linked to mutations in the hepatocyte nuclear factor-1alpha (MODY3) gene. Diabetes Care 28 (2005) 2774-2776
-
(2005)
Diabetes Care
, vol.28
, pp. 2774-2776
-
-
Malecki, M.T.1
Skupien, J.2
Gorczynska-Kosiorz, S.3
Klupa, T.4
Nazim, J.5
Moczulski, D.K.6
-
42
-
-
20044396943
-
Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection
-
Pearson E.R., Pruhova S., Tack C.J., Johansen A., Castleden H.A., Lumb P.J., et al. Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection. Diabetologia 48 (2005) 878-885
-
(2005)
Diabetologia
, vol.48
, pp. 878-885
-
-
Pearson, E.R.1
Pruhova, S.2
Tack, C.J.3
Johansen, A.4
Castleden, H.A.5
Lumb, P.J.6
-
43
-
-
35848955882
-
Macrosomia and neonatal hypoglycaemia in RW pedigree subjects with a mutation (Q268X) in the gene encoding hepatocyte nuclear factor 4alpha (HNF4A)
-
Fajans S.S., and Bell G.I. Macrosomia and neonatal hypoglycaemia in RW pedigree subjects with a mutation (Q268X) in the gene encoding hepatocyte nuclear factor 4alpha (HNF4A). Diabetologia 50 (2007) 2600-2601
-
(2007)
Diabetologia
, vol.50
, pp. 2600-2601
-
-
Fajans, S.S.1
Bell, G.I.2
-
44
-
-
34247500820
-
Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene
-
Pearson E.R., Boj S.F., Steele A.M., Barrett T., Stals K., Shield J.P., et al. Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene. PLoS Med. 4 (2007) e118
-
(2007)
PLoS Med.
, vol.4
-
-
Pearson, E.R.1
Boj, S.F.2
Steele, A.M.3
Barrett, T.4
Stals, K.5
Shield, J.P.6
-
45
-
-
0034035239
-
Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels
-
Shih D.Q., Dansky H.M., Fleisher M., Assmann G., Fajans S.S., Stoffel M., et al. Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride levels. Diabetes 49 (2000) 832-837
-
(2000)
Diabetes
, vol.49
, pp. 832-837
-
-
Shih, D.Q.1
Dansky, H.M.2
Fleisher, M.3
Assmann, G.4
Fajans, S.S.5
Stoffel, M.6
-
46
-
-
0036227445
-
Solitary functioning kidney and diverse genital tract malformations associated with hepatocyte nuclear factor-1beta mutations
-
Bingham C., Ellard S., Cole T.R., Jones K.E., Allen L.I., Goodship J.A., et al. Solitary functioning kidney and diverse genital tract malformations associated with hepatocyte nuclear factor-1beta mutations. Kidney Int. 61 (2002) 1243-1251
-
(2002)
Kidney Int.
, vol.61
, pp. 1243-1251
-
-
Bingham, C.1
Ellard, S.2
Cole, T.R.3
Jones, K.E.4
Allen, L.I.5
Goodship, J.A.6
-
47
-
-
0036329071
-
Renal cysts and diabetes syndrome linked to mutations of the hepatocyte nuclear factor-1 beta gene: description of a new family with associated liver involvement
-
Montoli A., Colussi G., Massa O., Caccia R., Rizzoni G., Civati G., et al. Renal cysts and diabetes syndrome linked to mutations of the hepatocyte nuclear factor-1 beta gene: description of a new family with associated liver involvement. Am. J. Kidney Dis. 40 (2002) 397-402
-
(2002)
Am. J. Kidney Dis.
, vol.40
, pp. 397-402
-
-
Montoli, A.1
Colussi, G.2
Massa, O.3
Caccia, R.4
Rizzoni, G.5
Civati, G.6
-
48
-
-
2342472176
-
Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1alpha and -1beta mutations
-
Pearson E.R., Badman M.K., Lockwood C.R., Clark P.M., Ellard S., Bingham C., et al. Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1alpha and -1beta mutations. Diabetes Care 27 (2004) 1102-1107
-
(2004)
Diabetes Care
, vol.27
, pp. 1102-1107
-
-
Pearson, E.R.1
Badman, M.K.2
Lockwood, C.R.3
Clark, P.M.4
Ellard, S.5
Bingham, C.6
-
49
-
-
12144286598
-
Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations
-
Bellanné-Chantelot C., Chauveau D., Gautier J.F., Dubois-Laforgue D., Clauin S., Beaufils S., et al. Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations. Ann. Intern. Med. 140 (2004) 510-517
-
(2004)
Ann. Intern. Med.
, vol.140
, pp. 510-517
-
-
Bellanné-Chantelot, C.1
Chauveau, D.2
Gautier, J.F.3
Dubois-Laforgue, D.4
Clauin, S.5
Beaufils, S.6
-
50
-
-
38949096076
-
Pancreatic exocrine dysfunction in maturity-onset diabetes of the young type 3
-
Vesterhus M., Raeder H., Johansson S., Molven A., and Njølstad P.R. Pancreatic exocrine dysfunction in maturity-onset diabetes of the young type 3. Diabetes Care 31 (2008) 306-310
-
(2008)
Diabetes Care
, vol.31
, pp. 306-310
-
-
Vesterhus, M.1
Raeder, H.2
Johansson, S.3
Molven, A.4
Njølstad, P.R.5
-
51
-
-
42549124531
-
Pancreatic exocrine insufficiency is not common in HNF-1alpha MODY
-
Klupa T., Skupien J., Gorczynska-Kosiorz S., Wanic K., Kusnierz-Cabala B., Solnica B., et al. Pancreatic exocrine insufficiency is not common in HNF-1alpha MODY. Diabet. Med. 25 (2008) 627-630
-
(2008)
Diabet. Med.
, vol.25
, pp. 627-630
-
-
Klupa, T.1
Skupien, J.2
Gorczynska-Kosiorz, S.3
Wanic, K.4
Kusnierz-Cabala, B.5
Solnica, B.6
-
52
-
-
0022356341
-
The insulin-pancreatic acinar axis
-
Williams J.A., and Golfie I.D. The insulin-pancreatic acinar axis. Diabetes 34 (1985) 980-986
-
(1985)
Diabetes
, vol.34
, pp. 980-986
-
-
Williams, J.A.1
Golfie, I.D.2
-
53
-
-
33644776570
-
Contrasting insulin sensitivity of endogenous glucose production rate in subjects with hepatocyte nuclear factor-1beta and -1alpha mutations
-
Brackenridge A., Pearson E.R., Shojaee-Moradie F., Hattersley A.T., Russell-Jones D., and Umpleby A.M. Contrasting insulin sensitivity of endogenous glucose production rate in subjects with hepatocyte nuclear factor-1beta and -1alpha mutations. Diabetes 55 (2006) 405-411
-
(2006)
Diabetes
, vol.55
, pp. 405-411
-
-
Brackenridge, A.1
Pearson, E.R.2
Shojaee-Moradie, F.3
Hattersley, A.T.4
Russell-Jones, D.5
Umpleby, A.M.6
-
54
-
-
0026849690
-
Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion
-
Ballinger S.W., Shoffner J.M., Hedaya E.V., Trounce I., Polak M.A., Koontz D.A., et al. Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nat. Genet. 1 (1992) 11-15
-
(1992)
Nat. Genet.
, vol.1
, pp. 11-15
-
-
Ballinger, S.W.1
Shoffner, J.M.2
Hedaya, E.V.3
Trounce, I.4
Polak, M.A.5
Koontz, D.A.6
-
55
-
-
0028328317
-
A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA
-
Kadowaki T., Kadowaki H., Mori Y., Tobe K., Sakuta R., Suzuki Y., et al. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N. Engl. J. Med. 330 (1994) 962-968
-
(1994)
N. Engl. J. Med.
, vol.330
, pp. 962-968
-
-
Kadowaki, T.1
Kadowaki, H.2
Mori, Y.3
Tobe, K.4
Sakuta, R.5
Suzuki, Y.6
-
56
-
-
0029914927
-
Maternally inherited diabetes and deafness: a new diabetes subtype
-
Maassen J.A., and Kadowaki T. Maternally inherited diabetes and deafness: a new diabetes subtype. Diabetologia 39 (1996) 375-382
-
(1996)
Diabetologia
, vol.39
, pp. 375-382
-
-
Maassen, J.A.1
Kadowaki, T.2
-
57
-
-
0842285626
-
Mitochondrial diabetes: molecular mechanisms and clinical presentation
-
Maassen J.A., 'tHart L.M., Van Essen E., Heine R.J., Nijpels G., Jahangir Tafrechi R.S., et al. Mitochondrial diabetes: molecular mechanisms and clinical presentation. Diabetes 53 Suppl. 1 (2004) S103-S109
-
(2004)
Diabetes
, vol.53
, Issue.SUPPL. 1
-
-
Maassen, J.A.1
'tHart, L.M.2
Van Essen, E.3
Heine, R.J.4
Nijpels, G.5
Jahangir Tafrechi, R.S.6
-
58
-
-
0027996170
-
Prevalence of maternally inherited diabetes and deafness in diabetic populations in The Netherlands
-
't Hart L.M., Lemkes H.H., Heine R.J., Stolk R.P., Feskens E.J., Jansen J.J., et al. Prevalence of maternally inherited diabetes and deafness in diabetic populations in The Netherlands. Diabetologia 37 (1994) 1169-1170
-
(1994)
Diabetologia
, vol.37
, pp. 1169-1170
-
-
't Hart, L.M.1
Lemkes, H.H.2
Heine, R.J.3
Stolk, R.P.4
Feskens, E.J.5
Jansen, J.J.6
-
59
-
-
41749086664
-
Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation
-
Murphy R., Turnbull D.M., Walker M., and Hattersley A.T. Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation. Diabet. Med. 25 (2008) 383-399
-
(2008)
Diabet. Med.
, vol.25
, pp. 383-399
-
-
Murphy, R.1
Turnbull, D.M.2
Walker, M.3
Hattersley, A.T.4
-
60
-
-
1642422307
-
Decrease of beta-cells and increase of alpha-cells in a diabetic patient with mitochondrial DNA 3243 (A→G) mutation
-
Kojima T., Yamamoto M., Furuhashi N., Sarui H., Takatsu H., Takeda N., et al. Decrease of beta-cells and increase of alpha-cells in a diabetic patient with mitochondrial DNA 3243 (A→G) mutation. Intern. Med. 42 (2003) 1193-1196
-
(2003)
Intern. Med.
, vol.42
, pp. 1193-1196
-
-
Kojima, T.1
Yamamoto, M.2
Furuhashi, N.3
Sarui, H.4
Takatsu, H.5
Takeda, N.6
-
61
-
-
33845496532
-
Maternally inherited diabetes and deafness in a North American kindred: tips for making the diagnosis and review of unique management issues
-
Donovan L.E., and Severin N.E. Maternally inherited diabetes and deafness in a North American kindred: tips for making the diagnosis and review of unique management issues. J. Clin. Endocrinol. Metab. 91 (2006) 4737-4742
-
(2006)
J. Clin. Endocrinol. Metab.
, vol.91
, pp. 4737-4742
-
-
Donovan, L.E.1
Severin, N.E.2
-
62
-
-
85056067838
-
Maternally inherited diabetes with deafness and obesity: body weight reduction response to treatment with insulin analogues
-
Malecki M.T., Skupien J., Klupa T., Naskalska A., Gorczynska-Kosiorz S., Moczulski D.K., et al. Maternally inherited diabetes with deafness and obesity: body weight reduction response to treatment with insulin analogues. Rev. Diabet. Stud. 3 (2006) 205-207
-
(2006)
Rev. Diabet. Stud.
, vol.3
, pp. 205-207
-
-
Malecki, M.T.1
Skupien, J.2
Klupa, T.3
Naskalska, A.4
Gorczynska-Kosiorz, S.5
Moczulski, D.K.6
-
63
-
-
0342902204
-
Neonatal diabetes mellitus due to complete glucokinase deficiency
-
Njolstad P.R., Sovik O., Cuesta-Munoz A., Bjørkhaug L., Massa O., Barbetti F., et al. Neonatal diabetes mellitus due to complete glucokinase deficiency. N. Engl. J. Med. 344 (2001) 1588-1592
-
(2001)
N. Engl. J. Med.
, vol.344
, pp. 1588-1592
-
-
Njolstad, P.R.1
Sovik, O.2
Cuesta-Munoz, A.3
Bjørkhaug, L.4
Massa, O.5
Barbetti, F.6
-
64
-
-
0031031571
-
Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence
-
Stoffers D.A., Zinkin N.T., Stanojevic V., Clarke W.L., and Habener J.F. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat. Genet. 15 (1997) 106-110
-
(1997)
Nat. Genet.
, vol.15
, pp. 106-110
-
-
Stoffers, D.A.1
Zinkin, N.T.2
Stanojevic, V.3
Clarke, W.L.4
Habener, J.F.5
-
65
-
-
0034425698
-
EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome
-
Delepine M., Nicolino M., Barrett T., Golamaully M., Lathrop G.M., Julier C., et al. EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat. Genet. 25 (2000) 406-409
-
(2000)
Nat. Genet.
, vol.25
, pp. 406-409
-
-
Delepine, M.1
Nicolino, M.2
Barrett, T.3
Golamaully, M.4
Lathrop, G.M.5
Julier, C.6
-
66
-
-
0035163909
-
X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy
-
Wildin R.S., Ramsdell F., Peake J., Faravelli F., Casanova J.L., Buist N., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27 (2001) 18-20
-
(2001)
Nat. Genet.
, vol.27
, pp. 18-20
-
-
Wildin, R.S.1
Ramsdell, F.2
Peake, J.3
Faravelli, F.4
Casanova, J.L.5
Buist, N.6
-
67
-
-
2342633204
-
Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes
-
Gloyn A.L., Pearson E.R., Antcliff J.F., Proks P., Bruining G.J., Slingerland A.S., et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N. Engl. J. Med. 350 (2004) 1838-1849
-
(2004)
N. Engl. J. Med.
, vol.350
, pp. 1838-1849
-
-
Gloyn, A.L.1
Pearson, E.R.2
Antcliff, J.F.3
Proks, P.4
Bruining, G.J.5
Slingerland, A.S.6
-
68
-
-
33746778878
-
Activating mutations in the ABCC8 gene in neonatal diabetes mellitus
-
Babenko A.P., Polak M., Cave H., Busiah K., Czernichow P., Scharfmann R., et al. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N. Engl. J. Med. 355 (2006) 456-466
-
(2006)
N. Engl. J. Med.
, vol.355
, pp. 456-466
-
-
Babenko, A.P.1
Polak, M.2
Cave, H.3
Busiah, K.4
Czernichow, P.5
Scharfmann, R.6
-
69
-
-
10644233000
-
Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features
-
Proks P., Antcliff J.F., Lippiat J., Gloyn A.L., Hattersley A.T., and Ashcroft F.M. Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 17539-17544
-
(2004)
Proc. Natl. Acad. Sci. U.S.A.
, vol.101
, pp. 17539-17544
-
-
Proks, P.1
Antcliff, J.F.2
Lippiat, J.3
Gloyn, A.L.4
Hattersley, A.T.5
Ashcroft, F.M.6
-
70
-
-
4644260056
-
Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy
-
Sagen J.V., Raeder H., Hathout E., Shehadeh N., Gudmundsson K., Baevre H., et al. Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. Diabetes 53 (2004) 2713-2718
-
(2004)
Diabetes
, vol.53
, pp. 2713-2718
-
-
Sagen, J.V.1
Raeder, H.2
Hathout, E.3
Shehadeh, N.4
Gudmundsson, K.5
Baevre, H.6
-
71
-
-
4644309915
-
Kir6.2 mutations are a common cause of permanent neonatal diabetes in a large cohort of French patients
-
Vaxillaire M., Populaire C., Busiah K., Cavé H., Gloyn A.L., Hattersley A.T., et al. Kir6.2 mutations are a common cause of permanent neonatal diabetes in a large cohort of French patients. Diabetes 53 (2004) 2719-2722
-
(2004)
Diabetes
, vol.53
, pp. 2719-2722
-
-
Vaxillaire, M.1
Populaire, C.2
Busiah, K.3
Cavé, H.4
Gloyn, A.L.5
Hattersley, A.T.6
-
72
-
-
19944427182
-
KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes
-
Massa O., Iafusco D., D'Amato E., Gloyn A.L., Hattersley A.T., Pasquino B., et al. KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes. Hum. Mutat. 25 (2005) 22-27
-
(2005)
Hum. Mutat.
, vol.25
, pp. 22-27
-
-
Massa, O.1
Iafusco, D.2
D'Amato, E.3
Gloyn, A.L.4
Hattersley, A.T.5
Pasquino, B.6
-
73
-
-
33746686369
-
Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations
-
Pearson E.R., Flechtner I., Njolstad P.R., Malecki M.T., Flanagan S.E., Larkin B., et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N. Engl. J. Med. 355 (2006) 467-477
-
(2006)
N. Engl. J. Med.
, vol.355
, pp. 467-477
-
-
Pearson, E.R.1
Flechtner, I.2
Njolstad, P.R.3
Malecki, M.T.4
Flanagan, S.E.5
Larkin, B.6
-
74
-
-
33746738864
-
Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene
-
Tonini G., Bizzarri C., Bonfanti R., Vanelli M., Cerutti F., Faleschini E., et al. Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene. Diabetologia 49 (2006) 2210-2213
-
(2006)
Diabetologia
, vol.49
, pp. 2210-2213
-
-
Tonini, G.1
Bizzarri, C.2
Bonfanti, R.3
Vanelli, M.4
Cerutti, F.5
Faleschini, E.6
-
75
-
-
33846008028
-
Transfer to sulphonylurea therapy of adult subjects with permanent neonatal diabetes due to KCNJ11 activating mutations: evidence for improvement in insulin sensitivity
-
Malecki M.T., Skupien J., Klupa T., Wanic K., Mlynarski W., Gach A., et al. Transfer to sulphonylurea therapy of adult subjects with permanent neonatal diabetes due to KCNJ11 activating mutations: evidence for improvement in insulin sensitivity. Diabetes Care 30 (2007) 147-149
-
(2007)
Diabetes Care
, vol.30
, pp. 147-149
-
-
Malecki, M.T.1
Skupien, J.2
Klupa, T.3
Wanic, K.4
Mlynarski, W.5
Gach, A.6
-
76
-
-
8744262895
-
Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2
-
Zung A., Glaser B., Nimri R., and Zadik Z. Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2. J. Clin. Endocrinol. Metab. 89 (2004) 5504-5507
-
(2004)
J. Clin. Endocrinol. Metab.
, vol.89
, pp. 5504-5507
-
-
Zung, A.1
Glaser, B.2
Nimri, R.3
Zadik, Z.4
-
77
-
-
35748967277
-
Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11
-
Mlynarski W., Tarasov A.I., Gach A., Girard C.A., Pietrzak I., Zubcevic L., et al. Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11. Nat. Clin. Pract. Neurol. 3 (2007) 640-645
-
(2007)
Nat. Clin. Pract. Neurol.
, vol.3
, pp. 640-645
-
-
Mlynarski, W.1
Tarasov, A.I.2
Gach, A.3
Girard, C.A.4
Pietrzak, I.5
Zubcevic, L.6
-
78
-
-
33744722778
-
A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes
-
Proks P., Arnold A.L., Bruining J., Girard C., Flanagan S.E., Larkin B., et al. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes. Hum. Mol. Genet. 15 (2006) 1793-1800
-
(2006)
Hum. Mol. Genet.
, vol.15
, pp. 1793-1800
-
-
Proks, P.1
Arnold, A.L.2
Bruining, J.3
Girard, C.4
Flanagan, S.E.5
Larkin, B.6
-
79
-
-
35148820198
-
Mutations in the ABCC8 gene encoding the SUR1 subunit of the KATP channel cause transient neonatal diabetes, permanent neonatal diabetes or permanent diabetes diagnosed outside the neonatal period
-
Patch A.M., Flanagan S.E., Boustred C., Hattersley A.T., and Ellard S. Mutations in the ABCC8 gene encoding the SUR1 subunit of the KATP channel cause transient neonatal diabetes, permanent neonatal diabetes or permanent diabetes diagnosed outside the neonatal period. Diabetes Obes. Metab. 9 Suppl. 2 (2007) 28-39
-
(2007)
Diabetes Obes. Metab.
, vol.9
, Issue.SUPPL. 2
, pp. 28-39
-
-
Patch, A.M.1
Flanagan, S.E.2
Boustred, C.3
Hattersley, A.T.4
Ellard, S.5
-
80
-
-
34547747922
-
Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects
-
Ellard S., Flanagan S.E., Girard C.A., Patch A.M., Harries L.W., Parrish A., et al. Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects. Am. J. Hum. Genet. 81 (2007) 375-382
-
(2007)
Am. J. Hum. Genet.
, vol.81
, pp. 375-382
-
-
Ellard, S.1
Flanagan, S.E.2
Girard, C.A.3
Patch, A.M.4
Harries, L.W.5
Parrish, A.6
-
81
-
-
38949177444
-
Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations
-
Neonatal Diabetes International Collaborative Group
-
Rafiq M., Flanagan S.E., Patch A.M., Shields B.M., Ellard S., Hattersley A.T., and Neonatal Diabetes International Collaborative Group. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Diabetes Care 31 (2008) 204-209
-
(2008)
Diabetes Care
, vol.31
, pp. 204-209
-
-
Rafiq, M.1
Flanagan, S.E.2
Patch, A.M.3
Shields, B.M.4
Ellard, S.5
Hattersley, A.T.6
-
82
-
-
42449102605
-
Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy: a report from the French ND (Neonatal Diabetes) Study Group
-
Polak M., Dechaume A., Cavé H., Nimri R., Crosnier H., Sulmont V., et al. Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy: a report from the French ND (Neonatal Diabetes) Study Group. Diabetes 57 (2008) 1115-1119
-
(2008)
Diabetes
, vol.57
, pp. 1115-1119
-
-
Polak, M.1
Dechaume, A.2
Cavé, H.3
Nimri, R.4
Crosnier, H.5
Sulmont, V.6
-
83
-
-
42449134450
-
Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood
-
Edghill E.L., Flanagan S.E., Patch A.M., Boustred C., Parrish A., Shields B., et al. Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 57 (2008) 1034-1042
-
(2008)
Diabetes
, vol.57
, pp. 1034-1042
-
-
Edghill, E.L.1
Flanagan, S.E.2
Patch, A.M.3
Boustred, C.4
Parrish, A.5
Shields, B.6
-
84
-
-
0036797965
-
Neonatal diabetes mellitus: neonatal diabetes mellitus: chromosomal analysis in transient and permanent cases
-
Metz C., Cave H., Bertrand A.M., Deffert C., Gueguen-Giroux B., Czernichow P., et al. Neonatal diabetes mellitus: neonatal diabetes mellitus: chromosomal analysis in transient and permanent cases. J. Pediatr. 141 (2002) 483-489
-
(2002)
J. Pediatr.
, vol.141
, pp. 483-489
-
-
Metz, C.1
Cave, H.2
Bertrand, A.M.3
Deffert, C.4
Gueguen-Giroux, B.5
Czernichow, P.6
-
85
-
-
0035167967
-
The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3
-
Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27 (2001) 20-21
-
(2001)
Nat. Genet.
, vol.27
, pp. 20-21
-
-
Bennett, C.L.1
Christie, J.2
Ramsdell, F.3
Brunkow, M.E.4
Ferguson, P.J.5
Whitesell, L.6
-
86
-
-
23944510233
-
Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome)
-
Bindl L., Torgerson T., Perroni L., Youssef N., Ochs H.D., Goulet O., et al. Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome). J. Pediatr. 47 (2005) 256-259
-
(2005)
J. Pediatr.
, vol.47
, pp. 256-259
-
-
Bindl, L.1
Torgerson, T.2
Perroni, L.3
Youssef, N.4
Ochs, H.D.5
Goulet, O.6
-
87
-
-
42949167333
-
Immune reconstitution and recovery of FOXP3 (forkhead box P3)-expressing T cells after transplantation for IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome
-
Zhan H., Sinclair J., Adams S., Cale C.M., Murch S., Perroni L., et al. Immune reconstitution and recovery of FOXP3 (forkhead box P3)-expressing T cells after transplantation for IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome. Pediatrics 121 (2008) e998-e1002
-
(2008)
Pediatrics
, vol.121
-
-
Zhan, H.1
Sinclair, J.2
Adams, S.3
Cale, C.M.4
Murch, S.5
Perroni, L.6
-
88
-
-
71749092573
-
Genotype-phenotype correlation in inherited severe insulin resistance
-
Longo N., Wang Y., Smith S.A., Langley S.D., DiMeglio L.A., and Giannella-Neto D. Genotype-phenotype correlation in inherited severe insulin resistance. Hum. Mol. Genet. 11 (2002) 1465-1475
-
(2002)
Hum. Mol. Genet.
, vol.11
, pp. 1465-1475
-
-
Longo, N.1
Wang, Y.2
Smith, S.A.3
Langley, S.D.4
DiMeglio, L.A.5
Giannella-Neto, D.6
-
89
-
-
27844525503
-
Monogenic syndromes of abnormal glucose homeostasis: clinical review and relevance to the understanding of the pathology of insulin resistance and beta cell failure
-
Porter J.R., and Barrett T.G. Monogenic syndromes of abnormal glucose homeostasis: clinical review and relevance to the understanding of the pathology of insulin resistance and beta cell failure. J. Med. Genet. 42 (2005) 893-902
-
(2005)
J. Med. Genet.
, vol.42
, pp. 893-902
-
-
Porter, J.R.1
Barrett, T.G.2
-
90
-
-
0026578917
-
Mutations in the insulin receptor gene in patients with genetic syndromes of insulin resistance and acanthosis nigricans
-
Accili D., Barbetti F., Cama A., Kadowaki H., Kadowaki T., Imano E., et al. Mutations in the insulin receptor gene in patients with genetic syndromes of insulin resistance and acanthosis nigricans. J. Invest. Dermatol. 89 (1992) 77S-81S
-
(1992)
J. Invest. Dermatol.
, vol.89
-
-
Accili, D.1
Barbetti, F.2
Cama, A.3
Kadowaki, H.4
Kadowaki, T.5
Imano, E.6
-
91
-
-
0025355589
-
Mutations in insulin-receptor gene in insulin-resistant patients
-
Taylor S.I., Kadowaki T., Kadowaki H., Accili D., Cama A., McKeon C., et al. Mutations in insulin-receptor gene in insulin-resistant patients. Diabetes Care 13 (1990) 257-279
-
(1990)
Diabetes Care
, vol.13
, pp. 257-279
-
-
Taylor, S.I.1
Kadowaki, T.2
Kadowaki, H.3
Accili, D.4
Cama, A.5
McKeon, C.6
-
92
-
-
0025579398
-
Mutations in the insulin receptor gene in genetic forms of insulin resistance
-
Taylor S.I., Kadowaki T., Accili D., Cama A., Kadowaki H., McKeon C., et al. Mutations in the insulin receptor gene in genetic forms of insulin resistance. Recent Prog. Horm. Res. 46 (1990) 185-213
-
(1990)
Recent Prog. Horm. Res.
, vol.46
, pp. 185-213
-
-
Taylor, S.I.1
Kadowaki, T.2
Accili, D.3
Cama, A.4
Kadowaki, H.5
McKeon, C.6
-
93
-
-
0027245458
-
Trial of insulinlike growth factor I therapy for patients with extreme insulin resistance syndromes
-
Kuzuya H., Matsuura N., Sakamoto M., Makino H., Sakamoto Y., Kadowaki T., et al. Trial of insulinlike growth factor I therapy for patients with extreme insulin resistance syndromes. Diabetes 42 (1993) 696-705
-
(1993)
Diabetes
, vol.42
, pp. 696-705
-
-
Kuzuya, H.1
Matsuura, N.2
Sakamoto, M.3
Makino, H.4
Sakamoto, Y.5
Kadowaki, T.6
-
94
-
-
0031733512
-
Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism
-
Nakae J., Kato M., Murashita M., Shinohara N., Tajima T., and Fujieda K. Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism. J. Clin. Endocrinol. Metab. 83 (1998) 542-549
-
(1998)
J. Clin. Endocrinol. Metab.
, vol.83
, pp. 542-549
-
-
Nakae, J.1
Kato, M.2
Murashita, M.3
Shinohara, N.4
Tajima, T.5
Fujieda, K.6
-
96
-
-
0036578783
-
AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34
-
Agarwal A.K., Arioglu E., De Almeida S., Akkoc N., Taylor S.I., Bowcock A.M., et al. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat. Genet. 31 (2002) 21-23
-
(2002)
Nat. Genet.
, vol.31
, pp. 21-23
-
-
Agarwal, A.K.1
Arioglu, E.2
De Almeida, S.3
Akkoc, N.4
Taylor, S.I.5
Bowcock, A.M.6
-
97
-
-
0034941121
-
Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13
-
Magre J., Delepine M., Khallouf E., Gedde-Dahl Jr. T., Van Maldergem L., Sobel E., et al. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat. Genet. 28 (2001) 365-370
-
(2001)
Nat. Genet.
, vol.28
, pp. 365-370
-
-
Magre, J.1
Delepine, M.2
Khallouf, E.3
Gedde-Dahl Jr., T.4
Van Maldergem, L.5
Sobel, E.6
-
98
-
-
0034059075
-
Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy
-
Cao H., and Hegele R.A. Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum. Mol. Genet. 9 (2000) 109-112
-
(2000)
Hum. Mol. Genet.
, vol.9
, pp. 109-112
-
-
Cao, H.1
Hegele, R.A.2
-
99
-
-
0034074434
-
Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes
-
Hegele R.A., Anderson C.M., Wang J., Jones D.C., and Cao H. Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes. Genome Res. 10 (2000) 652-658
-
(2000)
Genome Res.
, vol.10
, pp. 652-658
-
-
Hegele, R.A.1
Anderson, C.M.2
Wang, J.3
Jones, D.C.4
Cao, H.5
-
100
-
-
0033951216
-
LMNA, encoding lamin A/C, is mutated in partial lipodystrophy
-
Shackleton S., Lloyd D.J., Jackson S.N., Evans R., Niermeijer M.F., Singh B.M., et al. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat. Genet. 24 (2000) 153-156
-
(2000)
Nat. Genet.
, vol.24
, pp. 153-156
-
-
Shackleton, S.1
Lloyd, D.J.2
Jackson, S.N.3
Evans, R.4
Niermeijer, M.F.5
Singh, B.M.6
-
101
-
-
0033599038
-
Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension
-
Barroso I., Gurnell M., Crowley V.E., Agostini M., Schwabe J.W., Soos M.A., et al. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402 (1999) 880-883
-
(1999)
Nature
, vol.402
, pp. 880-883
-
-
Barroso, I.1
Gurnell, M.2
Crowley, V.E.3
Agostini, M.4
Schwabe, J.W.5
Soos, M.A.6
-
102
-
-
0036894397
-
PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy
-
Hegele R.A., Cao H., Frankowski C., Mathews S.T., and Leff T. PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy. Diabetes 51 (2002) 3586-3590
-
(2002)
Diabetes
, vol.51
, pp. 3586-3590
-
-
Hegele, R.A.1
Cao, H.2
Frankowski, C.3
Mathews, S.T.4
Leff, T.5
-
103
-
-
0344375097
-
Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma
-
Savage D.B., Tan G.D., Acerini C.L., Jebb S.A., Agostini M., Gurnell M., et al. Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma. Diabetes 52 (2003) 910-917
-
(2003)
Diabetes
, vol.52
, pp. 910-917
-
-
Savage, D.B.1
Tan, G.D.2
Acerini, C.L.3
Jebb, S.A.4
Agostini, M.5
Gurnell, M.6
-
104
-
-
12144291700
-
Tyrosine agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor gamma
-
Agostini M., Gurnell M., Savage D.B., Wood E.M., Smith A.G., Rajanayagam O., et al. Tyrosine agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor gamma. Endocrinology 145 (2004) 1527-1538
-
(2004)
Endocrinology
, vol.145
, pp. 1527-1538
-
-
Agostini, M.1
Gurnell, M.2
Savage, D.B.3
Wood, E.M.4
Smith, A.G.5
Rajanayagam, O.6
-
105
-
-
2542528670
-
A family with severe insulin resistance and diabetes due to a mutation in AKT2
-
George S., Rochford J.J., Wolfrum C., Gray S.L., Schinner S., Wilson J.C., et al. A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 304 (2004) 1325-1328
-
(2004)
Science
, vol.304
, pp. 1325-1328
-
-
George, S.1
Rochford, J.J.2
Wolfrum, C.3
Gray, S.L.4
Schinner, S.5
Wilson, J.C.6
-
106
-
-
10744220431
-
Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy
-
Agarwal A.K., Simha V., Oral E.A., Moran S.A., Gorden P., O'Rahilly S., et al. Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. J. Clin. Endocrinol. Metab. 88 (2003) 4840-4847
-
(2003)
J. Clin. Endocrinol. Metab.
, vol.88
, pp. 4840-4847
-
-
Agarwal, A.K.1
Simha, V.2
Oral, E.A.3
Moran, S.A.4
Gorden, P.5
O'Rahilly, S.6
-
107
-
-
0041668112
-
Kobberling type of familial partial lipodystrophy: an underrecognized syndrome
-
Herbst K.L., Tannock L.R., Deeb S.S., Purnell J.Q., Brunzell J.D., and Chait A. Kobberling type of familial partial lipodystrophy: an underrecognized syndrome. Diabetes Care 26 (2003) 1819-1824
-
(2003)
Diabetes Care
, vol.26
, pp. 1819-1824
-
-
Herbst, K.L.1
Tannock, L.R.2
Deeb, S.S.3
Purnell, J.Q.4
Brunzell, J.D.5
Chait, A.6
-
108
-
-
14844295735
-
Lessons from human mutations in PPARgamma
-
Hegele R.A. Lessons from human mutations in PPARgamma. Int. J. Obes. (Lond.) 29 Suppl. 1 (2005) S31-S35
-
(2005)
Int. J. Obes. (Lond.)
, vol.29
, Issue.SUPPL. 1
-
-
Hegele, R.A.1
-
109
-
-
0034663140
-
Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes
-
Arioglu E., Duncan-Morin J., Sebring N., Rother K.I., Gottlieb N., Lieberman J., et al. Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes. Ann. Intern. Med. 133 (2000) 263-274
-
(2000)
Ann. Intern. Med.
, vol.133
, pp. 263-274
-
-
Arioglu, E.1
Duncan-Morin, J.2
Sebring, N.3
Rother, K.I.4
Gottlieb, N.5
Lieberman, J.6
-
110
-
-
0642312212
-
Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene
-
Owen K.R., Donohoe M., Ellard S., and Hattersley A.T. Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene. Diabet. Med. 20 (2003) 823-827
-
(2003)
Diabet. Med.
, vol.20
, pp. 823-827
-
-
Owen, K.R.1
Donohoe, M.2
Ellard, S.3
Hattersley, A.T.4
-
111
-
-
0023201498
-
Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins
-
Newman B., Selby J.V., King M.C., Slemenda C., Fabsitz R., and Friedman G.D. Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 30 (1987) 763-768
-
(1987)
Diabetologia
, vol.30
, pp. 763-768
-
-
Newman, B.1
Selby, J.V.2
King, M.C.3
Slemenda, C.4
Fabsitz, R.5
Friedman, G.D.6
-
112
-
-
0032961820
-
The relative risks of hyperglycaemia, obesity and dyslipidaemia in the relatives of patients with Type II diabetes mellitus
-
Shaw J.T., Purdie D.M., Neil H.A., Levy J.C., and Turner R.C. The relative risks of hyperglycaemia, obesity and dyslipidaemia in the relatives of patients with Type II diabetes mellitus. Diabetologia 42 (1999) 24-27
-
(1999)
Diabetologia
, vol.42
, pp. 24-27
-
-
Shaw, J.T.1
Purdie, D.M.2
Neil, H.A.3
Levy, J.C.4
Turner, R.C.5
-
113
-
-
0035557623
-
Molecular diagnostics in monogenic and multifactorial forms of type 2 diabetes
-
McCarthy M.I., and Hattersley A.T. Molecular diagnostics in monogenic and multifactorial forms of type 2 diabetes. Expert Rev. Mol. Diagn. 4 (2001) 403-412
-
(2001)
Expert Rev. Mol. Diagn.
, vol.4
, pp. 403-412
-
-
McCarthy, M.I.1
Hattersley, A.T.2
-
114
-
-
34249885875
-
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
-
Scott L.J., Mohlke K.L., Bonnycastle L.L., Willer C.J., Li Y., Duren W.L., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316 (2007) 1341-1345
-
(2007)
Science
, vol.316
, pp. 1341-1345
-
-
Scott, L.J.1
Mohlke, K.L.2
Bonnycastle, L.L.3
Willer, C.J.4
Li, Y.5
Duren, W.L.6
-
115
-
-
34249888775
-
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
-
Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research
-
Voight B.F., Lyssenko V., Burtt N.P., de Bakker P.I., Chen H., Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research, Saxena R., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316 (2007) 1331-1336
-
(2007)
Science
, vol.316
, pp. 1331-1336
-
-
Voight, B.F.1
Lyssenko, V.2
Burtt, N.P.3
de Bakker, P.I.4
Chen, H.5
Saxena, R.6
-
116
-
-
34249895023
-
Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes
-
Zeggini E., Weedon M.N., Lindgren C.M., Frayling T.M., Elliott K.S., Lango H., et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316 (2007) 1336-1341
-
(2007)
Science
, vol.316
, pp. 1336-1341
-
-
Zeggini, E.1
Weedon, M.N.2
Lindgren, C.M.3
Frayling, T.M.4
Elliott, K.S.5
Lango, H.6
-
117
-
-
34547585382
-
Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study
-
Pearson E.R., Donnelly L.A., Kimber C., Whitley A., Doney A.S., McCarthy M.I., et al. Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study. Diabetes 56 (2007) 2178-2182
-
(2007)
Diabetes
, vol.56
, pp. 2178-2182
-
-
Pearson, E.R.1
Donnelly, L.A.2
Kimber, C.3
Whitley, A.4
Doney, A.S.5
McCarthy, M.I.6
|